---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-028330"
form_type: "8-K"
ticker: "ADVB"
cik: "0001941029"
company_name: "Advanced Biomed Inc."
filed_at: "2026-03-16T23:59:59+00:00"
generated_at: "2026-05-15T11:58:00.634739+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Advanced Biomed regains Nasdaq compliance after reverse stock split; stock remains listed

## Summary
- Received Panel decision on March 12, 2026 confirming compliance with Minimum Bid Price Rule.
- Reverse stock split completed Feb 20, 2026 brought closing bid price to $1.00+.
- Company will remain listed on Nasdaq subject to one-year Panel monitor under Rule 5815(d)(4)(A).
- Previously appealed delisting determination on Jan 21, 2026; hearing held Feb 17, 2026.

## SEC filing metadata
- accession: 0001213900-26-028330
- form_type: 8-K
- ticker: ADVB
- cik: 0001941029
- company_name: Advanced Biomed Inc.
- filed_at: 2026-03-16T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1941029/000121390026028330/0001213900-26-028330-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1941029/000121390026028330/ea0281688-8k_advanced.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-028330
- JSON: https://secwatch.observer/filing/0001213900-26-028330.json
- Plain text: https://secwatch.observer/filing/0001213900-26-028330.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.